02/05/2026
The reactivation of a common virus in the brain could trigger Alzheimer’s..
Scientists discover that the reactivation of the dormant herpes virus in the brain may drive the protein buildup responsible for cognitive decline.
For decades, the medical community viewed the brain as a sterile environment shielded by the blood-brain barrier. However, research into herpes simplex virus type 1 (HSV-1) is shattering that narrative. Scientists have discovered that this common virus, responsible for cold sores, can reside dormant in the brain before reactivating during periods of stress or aging. Once active, the virus appears to trigger the accumulation of amyloid and tau proteins—the toxic hallmarks of Alzheimer’s disease—particularly in those with a genetic predisposition. This suggests that what many consider a minor nuisance could actually be a significant driver of neurological damage.
This viral connection opens a revolutionary front in the fight against dementia. Clinical data shows that individuals vaccinated against related dormant viruses, like shingles, have a lower risk of developing cognitive impairment. Furthermore, laboratory models demonstrate that antiviral therapies can reduce the brain damage associated with viral reactivation. By shifting focus toward managing viral loads and using preventative vaccinations, researchers hope to intercept the progression of Alzheimer’s before it takes hold. These findings underscore the critical importance of viral health in maintaining cognitive function into our later years.
source: Itzhaki, R. Thirty years on: Our research into the link between herpes and Alzheimer’s. The Conversation.